Clinical Trial Update: A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting [Phase 1]

View source ↗

Summary

Phase 1 study to characterize how a new long-acting insulin behaves in the body during exercise and prolonged fasting in adults with Type 2 diabetes mellitus. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Investigational long-acting insulin (unnamed)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED